Growing evidence suggests an association between osteocalcin (OCN), a peptide derived from bone and involved in regulating glucose and lipid metabolism, and the risk of Alzheimer’s disease (AD). This evidence concerns the gene BGLAP and early-onset autosomal dominant Alzheimer disease.